Literature DB >> 6193348

Effective plasma concentrations of antiarrhythmic drugs against sustained halothane-adrenaline arrhythmia in dogs.

T Shibuya, K Hashimoto, S Imai.   

Abstract

We determined the minimum effective plasma concentrations of several antiarrhythmic agents against canine halothane-adrenaline arrhythmia. Sustained ventricular tachycardia was produced by continuous adrenaline infusion at rates of 1.5 to 4 micrograms/kg/min under 1.5% halothane anesthesia. Procainamide, 20 mg/kg, produced ventricular fibrillation in three of nine dogs. Disopyramide, 3 mg/kg, suppressed the arrhythmia in nine of 11 dogs at a minimum effective plasma concentration of 4.2 micrograms/ml, but produced ventricular fibrillation in the remaining two dogs. Phenytoin, 5 mg/kg, was effective at a minimum concentration of 12 micrograms/ml. Lidocaine, 10 mg/kg, suppressed the arrhythmia at a minimum concentration of 15 micrograms/ml, which is much higher than the human toxic plasma level. These drugs may have suppressed the adrenaline arrhythmia by inhibiting the sodium channel, because their effective concentrations were very close to membrane-stabilizing concentrations in vitro. Small doses of 30 micrograms/kg propranolol and 0.1 mg/kg N-696, two beta-blockers, and 0.1 mg/kg verapamil, a calcium channel blocker, yielding a concentration of 0.03 micrograms/ml, suppressed the arrhythmia, probably by indirectly or directly blocking the calcium channel.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193348     DOI: 10.1097/00005344-198307000-00005

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  9 in total

1.  Influence of ventilatory and circulatory changes on the pharmacokinetics of halothane and isoflurane.

Authors:  F J Frei; D A Thomson; A M Zbinden
Journal:  Experientia       Date:  1988-02-15

2.  Effects of antiarrhythmic drugs on the extraneuronal accumulation of isoprenaline in perfused rat hearts.

Authors:  K Sono; Y Akimoto; K Kurahashi; M Fujiwara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

3.  Effects of OPC-8212, a new positive inotropic agent, on canine ventricular arrhythmias.

Authors:  K Hashimoto; H Mitsuhashi
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

4.  Effects of a cardioselective M2 receptor antagonist, AF-DX 116, on ventricular arrhythmias in dogs.

Authors:  H Naito; Y Furukawa; K Hashimoto
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

5.  Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?

Authors:  K Hashimoto; A Haruno; T Matsuzaki; A Sugiyama; K Akiyama
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

6.  Effects of a new class I antiarrhythmic drug bidisomide on canine ventricular arrhythmia models.

Authors:  W Zhenjiu; T Awaji; A Hirasawa; S Motomura; K Hashimoto
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

7.  Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.

Authors:  K Hashimoto; M Ishii; S Komori; H Mitsuhashi
Journal:  Heart Vessels       Date:  1985-02       Impact factor: 2.037

8.  Antiarrhythmic effect of a new class 1 antiarrhythmic drug, AN-132, on ventricular arrhythmias in beagles.

Authors:  K Hashimoto; K Watanabe; H Mitsuhashi
Journal:  Cardiovasc Drugs Ther       Date:  1989-10       Impact factor: 3.727

9.  Use of adrenaline continuous infusion to treat hypotension during general anaesthesia in a cow and a calf.

Authors:  Laura Gómez Fernández; María Chie Niimura Del Barrio; Claire Loughran
Journal:  Ir Vet J       Date:  2020-07-02       Impact factor: 2.146

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.